Literature DB >> 21157109

Assessment of plasma miRNAs in congestive heart failure.

Yasue Fukushima1, Michio Nakanishi, Hiroshi Nonogi, Yoichi Goto, Naoharu Iwai.   

Abstract

BACKGROUND: MicroRNAs (miRNAs) are endogenous small RNAs that are 21-25 nucleotides in length. Recently, plasma miRNAs have been reported to be sensitive and specific biomarkers of various tissue injuries and pathological conditions. The goal of this study was to assess plasma miRNA profiles and to identify plasma miRNAs that are differentially expressed in patients with heart failure. METHODS AND
RESULTS: A total of 33 patients with ischemic heart diseases and 17 asymptomatic controls were recruited. In 10 patients with heart failure, miRNAs were assessed at both NYHA IV and III. miRNA array analyses were found to be not appropriate for plasma miRNA profiling. The plasma concentrations of well-characterized miRNAs (miR-126, 122 and 499) were assessed by a real-time reverse transcription-polymerase chain reaction using an artificial small RNA as an internal standard. Plasma concentrations of miR-126 were negatively correlated with age and logBNP. In 10 patients with heart failure, plasma concentrations of miR-126 were up-regulated with improvement of the NYHA class from IV to III.
CONCLUSIONS: The plasma concentration of miR-126 was negatively correlated with age and NYHA class, and could be a useful biomarker for heart failure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21157109     DOI: 10.1253/circj.cj-10-0457

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  68 in total

Review 1.  Circulating microRNAs: novel biomarkers for cardiovascular diseases.

Authors:  Jiahong Xu; Jiangmin Zhao; Graham Evan; Chunyang Xiao; Yan Cheng; Junjie Xiao
Journal:  J Mol Med (Berl)       Date:  2011-12-08       Impact factor: 4.599

Review 2.  Diagnostic and prognostic value of circulating microRNAs in heart failure with preserved and reduced ejection fraction.

Authors:  Christian Schulte; Dirk Westermann; Stefan Blankenberg; Tanja Zeller
Journal:  World J Cardiol       Date:  2015-12-26

3.  Effects of microRNA-139 on myocardial cell injury induced by oxidative stress.

Authors:  Tao Li; Sumei Liang; Yuxiu Zhang; Yongqing Chen
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 4.  Clinical use of novel biomarkers in heart failure: towards personalized medicine.

Authors:  Daniela Schmitter; Gadi Cotter; Adriaan A Voors
Journal:  Heart Fail Rev       Date:  2014-05       Impact factor: 4.214

Review 5.  Mechanisms and therapeutic potential of microRNAs in hypertension.

Authors:  Lijun Shi; Jingwen Liao; Bailin Liu; Fanxing Zeng; Lubo Zhang
Journal:  Drug Discov Today       Date:  2015-05-21       Impact factor: 7.851

6.  Circulating microRNAs levels in Chinese heart failure patients caused by dilated cardiomyopathy.

Authors:  Kuan-Lu Fan; Hai-Feng Zhang; Jie Shen; Qi Zhang; Xin-Li Li
Journal:  Indian Heart J       Date:  2012-12-28

Review 7.  Circulating microRNAs in cardiovascular diseases: from biomarkers to therapeutic targets.

Authors:  Feng Wang; Chen Chen; Daowen Wang
Journal:  Front Med       Date:  2014-12-01       Impact factor: 4.592

Review 8.  Circulating miRNAs: reflecting or affecting cardiovascular disease?

Authors:  Vanessa P M van Empel; Leon J De Windt; Paula A da Costa Martins
Journal:  Curr Hypertens Rep       Date:  2012-12       Impact factor: 5.369

Review 9.  MicroRNAs as biomarkers for ischemic heart disease.

Authors:  Lucas N L Van Aelst; Stephane Heymans
Journal:  J Cardiovasc Transl Res       Date:  2013-05-29       Impact factor: 4.132

10.  Comparative RNA-sequencing analysis of myocardial and circulating small RNAs in human heart failure and their utility as biomarkers.

Authors:  Kemal Marc Akat; D'Vesharronne Moore-McGriff; Pavel Morozov; Miguel Brown; Tasos Gogakos; Joel Correa Da Rosa; Aleksandra Mihailovic; Markus Sauer; Ruiping Ji; Aarthi Ramarathnam; Hana Totary-Jain; Zev Williams; Thomas Tuschl; P Christian Schulze
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.